At the same time, the number of patients being treated for glaucoma grew at an estimated 3.8 percent, according to Market Scope’s latest survey of glaucoma specialists.
An FDA advisory panel meeting to review the lens will be rescheduled after a wintry mix forced cancellation on February 14.
In 2004, there were less than 50,000 multifocal IOLs implanted globally. We project the number in 2014 will reach well over 600 thousand.
Ellex’ resources may expand sales of iScience’s iTrack 250 microcatheter, which is used in canaloplasty procedures for the treatment of glaucoma.
Globally, the market is expected to approach $1.0 billion in 2014 and nearly $1.25 billion in 2019 at a compounded annual growth rate of 5 percent.
You are not currently logged in.
©2017 Market Scope
Lost your Password